Effects of Adiponectin Receptor Agonist on Heart Health in Mice with Duchenne Muscular Dystrophy
Author Information
Author(s): Abou-Samra Michel, Dubuisson Nicolas, Marino Alice, Selvais Camille M., Romain Versele, Davis-López de Carrizosa Maria A., Noel Laurence, Beauloye Christophe, Brichard Sonia M., Horman Sandrine
Primary Institution: Université Catholique de Louvain (UCLouvain)
Hypothesis
Can AdipoRon improve cardiac function and reduce inflammation in aged mdx mice with Duchenne muscular dystrophy?
Conclusion
AdipoRon treatment significantly protects the heart in aged mdx mice by reducing inflammation, fibrosis, and hypertrophy while enhancing mitochondrial function.
Supporting Evidence
- AdipoRon treatment reversed cardiac dysfunction in mdx mice.
- Inflammatory markers were significantly reduced in treated mice.
- Cardiac fibrosis and hypertrophy were mitigated by AdipoRon.
- Enhanced mitochondrial biogenesis was observed in the hearts of treated mice.
- Overall muscle strength and endurance improved in mdx mice after treatment.
Takeaway
AdipoRon is a medicine that helps the hearts of sick mice get better and stronger, making them feel healthier.
Methodology
14-month-old mdx mice were treated with AdipoRon for two months, and their heart function was assessed using echocardiography and various biochemical tests.
Potential Biases
Potential bias in the selection of treatment groups and outcomes measured.
Limitations
The study was conducted on a mouse model, which may not fully replicate human conditions.
Participant Demographics
14-month-old male mdx mice and wild-type controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website